Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Scientific Reports|January 22, 2021
Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19Ilario De Toma, Mara Dierssen
Plos Computational Biology|September 27, 2021
Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndromeIlario De Toma, Cesar Sierra, Mara Dierssen
Frontiers in Molecular Neuroscience|December 6, 2019
DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental EnrichmentIlario De Toma, Mireia Ortega, Patrick Aloy, et al.
Elife|January 15, 2016
NF-κB oscillations translate into functionally related patterns of gene expressionSamuel Zambrano, Ilario De Toma, Arianna Piffer, et al.
Molecular Aspects of Medicine|July 19, 2019
The importance of long non-coding RNAs in neuropsychiatric disordersEbrahim Hosseini, Zahra Bagheri-Hosseinabadi, Ilario De Toma, et al.
Frontiers in Behavioral Neuroscience|November 22, 2021
Social Factors Influence Behavior in the Novel Object Recognition Task in a Mouse Model of Down SyndromeCesar Sierra, Ilario De Toma, Lorenzo Lo Cascio, et al.
Ageing Research Reviews|September 25, 2020
Transposable elements in brain health and diseaseAmirhossein Ahmadi, Ilario De Toma, Natàlia Vilor-Tejedor, et al.
Frontiers in Molecular Neuroscience|January 2, 2023
Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate geneMireia Ortega, Ilario De Toma, Álvaro Fernández-Blanco, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 7, 2021
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disordersLaura Xicota, Ilario De Toma, Elisabetta Maffioletti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 12, 2018
Translating molecular advances in Down syndrome and Fragile X syndrome into therapiesVictor Faundez, Ilario De Toma, Barbara Bardoni, et al.
Pageof 2